They stated that they are expecting to enroll another patient in mid January if the FDA liked the two months of data from the October patient, no? Additionally I thought that getting approval for the 2nd patient also meant that they could enroll more patients? Which would infer that the data from the first patient was positive even if they don't state it until a scientific forum or what not...IMO
The progress the first patient is already making is stunning considering the injury.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.